Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,764 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06907069Enrolling by invitationPhase 4
Combined treatment for drug-resistant bacteria in lung infections
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
Ningbo, ZAges 18–80 - NCT06570850RecruitingPhase 4
Colistin alone vs colistin plus fosfomycin for CRAB infections
This study compares colistin by itself versus colistin combined with fosfomycin to see which works better for certain infections caused by CRAB bacteria. The goal is to help patients with pneumonia, urinary tract, skin, or bloodstream infections.
Chiang MaiAges 20 years+ - NCT06331364Recruiting
Treating lung infections with better antibiotic decisions in Sri Lanka
This study tests whether a new way of deciding when to use antibiotics helps patients with lower respiratory infections (like pneumonia or bronchitis) in Sri Lankan hospitals. If you were recently admitted with a new lung infection, you may be able to join.
BalapitiyaAges 14 years+ - NCT06561698RecruitingPhase 4
High-dose dual therapy vs minocycline quadruple therapy for H. pylori
This trial compares two treatments for H. pylori infection: a high-dose two-drug regimen and a four-drug regimen containing minocycline. It aims to find which is more effective and better tolerated.
Hebi, HenanAges 18–70 - NCT06791382Recruiting
AI infection risk study for hospital patients
This study uses an artificial intelligence system to analyze electronic health records and predict which hospital patients might develop an infection. If you join, your health data will be used to train the AI, which could help prevent infections in the future.
Wenzhou, ZhejiangAges birth–90 years - NCT05640336Enrolling by invitation
Antibiotics for early knee or hip joint infections after surgery
This study compares two antibiotic plans for acute (early) infections around an artificial knee or hip, using a procedure to clean the joint and try to keep the implant. It may help find the best approach to control infection and then prevent it from coming back with longer-term antibiotic treatment.
Jacksonville, FloridaAges 18 years+ - NCT07666464RecruitingPhase 3
Saline wash for complicated lung infections
This trial tests if washing the infected fluid in the chest with salt water (saline) early on helps treat complicated lung infections better than the usual care. It may improve recovery and reduce the need for surgery.
Amiens, PicardieAges 18 years+ - NCT06387667Recruiting
Fungal lung infections in ICU patients with weak immune systems
This study looks at different types of fungi that may cause serious lung infections in patients with weakened immune systems in the ICU. It aims to find out which fungi are present and which antifungal drugs can kill them.
AsyutAges 18 years+ - NCT06126614RecruitingPhase 3
Infection prevention in joint replacement surgery
This trial tests a way to prevent infections for people getting a hip or knee replacement. It compares different methods to see which works best and may help lower your risk of infection after surgery.
Hamilton, OntarioAges 18 years+ - NCT07222670RecruitingPhase 2
Study of INNA-051 to prevent viral respiratory illness in healthy adults
This trial tests whether INNA-051 can help prevent respiratory infections caused by viruses in healthy adults aged 18 to 45. It may be an option if you are at higher risk of catching such infections due to your living or work situation.
Baltimore, MarylandAges 18–45 - NCT07183592Recruiting
Changing IV tubing in the ICU: does less often harm?
This trial compares changing the tubing attached to central lines every 4 days versus every 7 days, to see if less frequent changes cause more infections. If you have a central line in the ICU that will stay in for at least a week, this study may help decide the safest schedule.
Saint-Pierre, La RéunionAges 18 years+ - NCT06102044RecruitingPhase 3
Zinc for young infants with severe infection in Tanzania
This study tests whether giving zinc supplements to very young babies (under 2 months) with severe infections helps them recover better. It takes place in Tanzania and involves adding zinc to their regular care.
Dar es SalaamAges birth–2 months - NCT07717372Recruiting
CRP test for adults with respiratory infection in primary care
This trial tests whether a simple finger-prick test (C-reactive protein or CRP) can help doctors decide whether antibiotics are needed for adults with a cold or other respiratory infection. If you are an adult with recent symptoms and have not taken antibiotics yet, you may be able to join.
JakartaAges 18 years+ - NCT07704255RecruitingPhase 4
Fecal transplant for stubborn H. pylori infection
This study tries a fecal microbiota transplant (placing healthy donor stool into your gut) to get rid of stubborn H. pylori infection that hasn't been cured by standard treatments. It's for people who have failed several rounds of therapy and have a stomach condition that makes eradication important.
Chengdu, SichuanAges 18–80 - NCT07544212Recruiting
Infections after large leg prosthesis implants: tracking outcomes
This study examines infections that occur after people receive a large custom prosthesis (artificial leg) to replace lost bone or tissue. Researchers want to understand who gets infections, why, and how these infections affect long-term health and function.
Bologna, BOAges 14–100 - NCT07432373Recruiting
Comparing clot-busting drugs for lung infections
This trial tests two combinations of medicines for people with infected fluid around the lung that isn't draining well through a chest tube. The goal is to see which combination works better to clear the infection and improve recovery.
Cheras, Kuala LumpurAges 18 years+ - NCT06714864RecruitingPhase 4
Preventing catheter infections in children on dialysis
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
Birmingham, AlabamaAges Up to 17 years - NCT07744321Recruiting
Bacteria in stool during long ICU stays
This study looks at how certain bacteria (Klebsiella pneumoniae and Enterobacter cloacae) change over time in the stool of ICU patients staying at least 28 days. It aims to understand why these infections occur and how they evolve, which could help improve future care.
CaenAges 18 years+ - NCT07739446Enrolling by invitation
Do face masks help prevent catching the flu or COVID-19?
This trial looks at whether wearing surgical masks when out in public can reduce your chances of getting the flu or COVID-19. If you join, you'll be assigned by chance to either wear a mask outside for 3-4 months or not wear one, and you'll be tested if you get sick.
ChibaAges 20–49 - NCT06970262Recruiting
Fecal transplant for tough lung infections on a ventilator
This study tests whether a treatment called fecal microbiota transplantation (FMT) can help clear stubborn lung infections (MDRO) in people who are in the ICU on a ventilator. The goal is to see if FMT can improve recovery and reduce the risk of further organ problems.
WuhanAges 18–70 - NCT05069688RecruitingPhase 1
Testing dolutegravir dosing in HIV and TB children
This study looks at the right way to dose dolutegravir (an HIV medicine) in young children who also have active tuberculosis (TB). Doctors will measure how the medicine moves through the body, especially when standard vs higher-dose rifampicin is used.
Ibadan, Oyo StateAges 4 weeks–5 years - NCT07725263Recruiting
Low-dose antifungal for kids with low white blood cells
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent serious fungal infections in children whose immune system is weak after cancer treatment or a stem cell transplant. It's for kids aged 3 to 17 who are at high risk for these infections.
Haikou, HainanAges 3–17 - NCT04419870Recruiting
Studying infections and immune responses in mitochondrial disease
This study looks at what happens in the body when someone with mitochondrial disease gets a sudden (acute) infection, and how the immune system and metabolism respond. Results may help doctors better recognize and manage infections in people with mitochondrial disease.
Bethesda, MarylandAges 2 months–115 years - NCT05624450RecruitingPhase 3
Test drug tozorakimab for hospitalized viral lung infection needing oxygen
This Phase 3 study tests tozorakimab to see if it helps people hospitalized with a viral lung infection that is causing low oxygen levels. You might qualify if you still need supplemental oxygen when the study starts.
Mobile, AlabamaAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,764 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.